Cargando…
Serum Visfatin/NAMPT as a Potential Risk Predictor for Malignancy of Adrenal Tumors
Adrenocortical carcinomas (ACC) are rare endocrine malignancies, often with a poor prognosis. Visfatin/NAMPT regulates a variety of signaling pathway components, and its overexpression has been found in carcinogenesis. Our study aimed to assess the clinical usefulness of visfatin/NAMPT serum level i...
Autores principales: | Sawicka-Gutaj, Nadia, Komarowska, Hanna, Gruszczyński, Dawid, Derwich, Aleksandra, Klimont, Anna, Ruchała, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572558/ https://www.ncbi.nlm.nih.gov/pubmed/36233428 http://dx.doi.org/10.3390/jcm11195563 |
Ejemplares similares
-
Is eNAMPT/visfatin a potential serum marker of papillary thyroid
cancer?
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2022) -
Circulating Visfatin in Hypothyroidism Is Associated with Free Thyroid Hormones and Antithyroperoxidase Antibodies
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2016) -
Effect of restoration of euthyroidism on visfatin concentrations and body composition in women
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021) -
Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
por: Derwich, Aleksandra, et al.
Publicado: (2023) -
The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review
por: Derwich, Aleksandra, et al.
Publicado: (2023)